Old Web
English
Sign In
Acemap
>
authorDetail
>
K.M. Grebe
K.M. Grebe
Immunology
Medicine
Pharmacodynamics
Lupus erythematosus
Tolerability
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus:
2018
Lupus
P. Lu
R. Fleischmann
C. Curtis
S. Ignatenko
S.H. Clarke
M. Desai
S. L. Wong
K.M. Grebe
K Black
J. Zeng
J. Stolzenbach
J. Medema
Show All
Source
Cite
Save
Citations (15)
THU0306 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of The BCL-2 Inhibitor Venetoclax (ABT-199) in A Phase 1 Single and Multiple Ascending Dose Study in Female Patients with Systemic Lupus Erythematosus
2016
Annals of the Rheumatic Diseases
P. Lu
R. Fleischmann
C. Curtis
S. Ignatenko
M. Desai
S. L. Wong
K.M. Grebe
J. Zeng
J. Medema
J. Stolzenbach
Show All
Source
Cite
Save
Citations (0)
Lack of adalimumab's complement dependent cytotoxicity on human cells expressing complement regulatory proteins.
2010
Journal of Translational Medicine
K.M. Grebe
Jochen G. Salfeld
Zehra Kaymakcalan
Show All
Source
Cite
Save
Citations (1)
1